Tong Dai, MD: Considering all the options, it looks like if the patient needs faster response, pembrolizumab plus lenvatinib ...
Don’t reserve your best business thinking for your career. by Clayton M. Christensen Before I published The Innovator’s Dilemma, I got a call from Andrew Grove, then the chairman of Intel. He had read ...
Discover a study examining epinephrine for anaphylaxis safety, highlighting cardiovascular risks, correct dosing, and why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback